Published in PLoS One on October 27, 2010
Artificial Neural Networks-Based Software for Measuring Heat Collection Rate and Heat Loss Coefficient of Water-in-Glass Evacuated Tube Solar Water Heaters. PLoS One (2015) 1.36
Bariatric surgery: the challenges with candidate selection, individualizing treatment and clinical outcomes. BMC Med (2013) 1.10
Early postoperative weight loss predicts maximal weight loss after sleeve gastrectomy and Roux-en-Y gastric bypass. Surg Endosc (2014) 0.81
Comparisons of prediction models of quality of life after laparoscopic cholecystectomy: a longitudinal prospective study. PLoS One (2012) 0.79
Prediction of excess weight loss after laparoscopic Roux-en-Y gastric bypass: data from an artificial neural network. Surg Endosc (2015) 0.78
Seasonal variation in the voluntary food intake of domesticated cats (Felis catus). PLoS One (2014) 0.78
Prediction of in-hospital mortality after ruptured abdominal aortic aneurysm repair using an artificial neural network. J Vasc Surg (2015) 0.75
Impaired weight loss in laparoscopic adjustable gastric banding patients over 50 years of age: diabetes mellitus as an independent risk factor. Surg Endosc (2015) 0.75
Update on obesity. J Clin Endocrinol Metab (2008) 1.65
Review of meta-analytic comparisons of bariatric surgery with a focus on laparoscopic adjustable gastric banding. Surg Obes Relat Dis (2008) 1.61
Treatment modalities of obesity: what fits whom? Diabetes Care (2008) 1.58
Psychosocial predictors of success following bariatric surgery. Obes Surg (2005) 1.54
Sweet eating is not a predictor of outcome after Lap-Band placement. Can we finally bury the myth? Obes Surg (2002) 1.46
Hunger control and regular physical activity facilitate weight loss after laparoscopic adjustable gastric banding. Obes Surg (2008) 1.31
Post-surgery adherence to scheduled visits and compliance, more than personality disorders, predict outcome of bariatric restrictive surgery in morbidly obese patients. Obes Surg (2007) 1.30
Psychosocial predictors of weight loss after bariatric surgery. Obes Surg (2006) 1.20
Predictive factors of outcome after gastric banding: a nationwide survey on the role of center activity and patients' behavior. Ann Surg (2007) 1.10
Outcome predictors in morbidly obese recipients of an adjustable gastric band. Obes Surg (2002) 1.10
Surgical management of morbid obesity. Curr Probl Surg (2008) 1.04
The history and role of gastric banding. Surg Obes Relat Dis (2008) 1.01
Who benefits from gastric banding? Obes Surg (2007) 0.99
Axis I and II disorders and quality of life in bariatric surgery candidates. J Clin Psychiatry (2008) 0.97
Selection of patients for anti-obesity surgery. Int J Obes Relat Metab Disord (2001) 0.93
Predictors of outcome in treatment of morbid obesity by laparoscopic adjustable gastric banding: results of a prospective study of 380 patients. Surg Obes Relat Dis (2008) 0.92
Safety and efficacy of laparoscopic adjustable gastric banding in the elderly. Obesity (Silver Spring) (2008) 0.90
Initiation and maintenance of weight loss after laparoscopic adjustable gastric banding. The role of outcome expectation and satisfaction with the psychosocial outcome. Obes Surg (2008) 0.87
MMPI-2 scores in the outcome prediction of gastric bypass surgery. Obes Surg (2004) 0.85
Prediction of successful weight reduction after bariatric surgery by data mining technologies. Obes Surg (2007) 0.84
Selecting the optimal patient for LAP-BAND placement. Am J Surg (2002) 0.83
Treating morbid obesity with laparoscopic adjustable gastric banding. Am J Surg (2007) 0.82
Utility of the temperament and character inventory (TCI) in outcome prediction of laparoscopic adjustable gastric banding: preliminary report. Obes Surg (2006) 0.80
Age > or =50 does not influence outcome in laparoscopic gastric banding. Obes Surg (2008) 0.79
Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst (2005) 5.32
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab (2008) 3.38
Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot (2006) 3.03
Europe is iodine deficient. Lancet (2003) 2.99
American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract (2010) 2.97
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab (2007) 2.74
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol (2008) 2.70
Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid (2008) 2.65
Electroconvulsive therapy in 197 patients with a severe, drug-resistant bipolar mixed state: treatment outcome and predictors of response. J Clin Psychiatry (2015) 2.05
Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab (2004) 1.82
Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. J Clin Endocrinol Metab (2002) 1.81
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. J Clin Endocrinol Metab (2004) 1.79
Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab (2004) 1.75
Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challenge. Clin Chem (2009) 1.71
Minimally invasive video-assisted thyroidectomy for papillary carcinoma: a prospective study of its completeness. Surgery (2002) 1.71
Symptom fluctuation in eating disorders: correlates of diagnostic crossover. Am J Psychiatry (2005) 1.69
Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid (2004) 1.69
Efficacy of ECT in depression: a meta-analytic review. J ECT (2004) 1.64
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J Clin Endocrinol Metab (2010) 1.63
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. J Clin Endocrinol Metab (2012) 1.62
Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med (2003) 1.55
Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients. J Clin Endocrinol Metab (2004) 1.52
Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab (2007) 1.51
Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases. J Clin Endocrinol Metab (2010) 1.50
Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey. Br J Ophthalmol (2006) 1.45
Low prevalence of the somatic M918T RET mutation in micro-medullary thyroid cancer. Thyroid (2012) 1.45
Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women. High Blood Press Cardiovasc Prev (2012) 1.42
Subcutaneous adipose tissue blood flow and vasomotion in morbidly obese patients: long term effect of gastric bypass surgery. Clin Hemorheol Microcirc (2012) 1.41
Exacerbation of autoimmune thyroiditis following bilateral adrenalectomy for Cushing's syndrome. Thyroid (2010) 1.39
Epidemiology and management of neuropsychiatric disorders in Behçet's syndrome. CNS Drugs (2015) 1.39
Application of a latent class analysis to empirically define eating disorder phenotypes. Arch Gen Psychiatry (2004) 1.39
Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab (2004) 1.32
RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. J Clin Endocrinol Metab (2007) 1.31
Gene expression in ductus arteriosus and aorta: comparison of birth and oxygen effects. Physiol Genomics (2006) 1.30
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. Eur J Endocrinol (2003) 1.29
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer. Endocr Relat Cancer (2008) 1.26
RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population. J Clin Endocrinol Metab (2004) 1.26
Alcohol use disorder comorbidity in eating disorders: a multicenter study. J Clin Psychiatry (2004) 1.26
Risk factors for congenital hypothyroidism: results of a population case-control study (1997-2003). Eur J Endocrinol (2005) 1.22
Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology (2010) 1.22
Parathyroid carcinoma. J Bone Miner Res (2008) 1.20
Assessment of nodular goitre. Best Pract Res Clin Endocrinol Metab (2010) 1.20
The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center. J Clin Endocrinol Metab (2011) 1.18
Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis. J Autoimmun (2007) 1.18
Vascular generation of tumor necrosis factor-α reduces nitric oxide availability in small arteries from visceral fat of obese patients. J Am Coll Cardiol (2011) 1.16
From the third month of pregnancy to 1 year postpartum. Prevalence, incidence, recurrence, and new onset of depression. Results from the perinatal depression-research & screening unit study. Compr Psychiatry (2010) 1.15
Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers. J Proteome Res (2008) 1.14
Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules. Best Pract Res Clin Endocrinol Metab (2008) 1.13
Ala147Thr substitution in translocator protein is associated with adult separation anxiety in patients with depression. Psychiatr Genet (2009) 1.13
Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. J Clin Endocrinol Metab (2012) 1.12
Obesity cardiomyopathy: is it a reality? An ultrasonic tissue characterization study. J Am Soc Echocardiogr (2006) 1.12
Genetic analysis of bulimia nervosa: methods and sample description. Int J Eat Disord (2004) 1.11
Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? Eur J Endocrinol (2007) 1.09
Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy. Thyroid (2004) 1.09
Cellular program controlling the recovery of adipose tissue mass: An in vivo imaging approach. Proc Natl Acad Sci U S A (2008) 1.09
Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patients. Diabetes (2013) 1.09
Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids. J Clin Endocrinol Metab (2007) 1.08
Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. Am J Psychiatry (2002) 1.08
Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal. J Clin Endocrinol Metab (2009) 1.08
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. J Clin Endocrinol Metab (2012) 1.08
Low prevalence of thyrotropin receptor mutations in a large series of subjects with sporadic and familial nonautoimmune subclinical hypothyroidism. J Clin Endocrinol Metab (2004) 1.07
Significant linkage on chromosome 10p in families with bulimia nervosa. Am J Hum Genet (2002) 1.07
Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am J Pathol (2002) 1.06
Radionuclide gastroesophageal motor studies. J Nucl Med (2004) 1.06
Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells. J Lipid Res (2003) 1.05
Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy. J Clin Endocrinol Metab (2009) 1.04
Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin. J Clin Endocrinol Metab (2012) 1.04
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. Eur J Endocrinol (2010) 1.04
Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies. J Clin Endocrinol Metab (2007) 1.03
Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease. J Clin Endocrinol Metab (2002) 1.01
Contribution of 32 GWAS-identified common variants to severe obesity in European adults referred for bariatric surgery. PLoS One (2013) 1.01
Outcome of Graves' orbitopathy after total thyroid ablation and glucocorticoid treatment: follow-up of a randomized clinical trial. J Clin Endocrinol Metab (2011) 1.00
Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. Thyroid (2012) 1.00
The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. Thyroid (2003) 1.00
Real-time PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissues. Eur J Endocrinol (2002) 1.00